Association of IA-2 autoantibodies with HLA DR4 phenotypes in IDDM
- 1 October 1996
- journal article
- Published by Springer Nature in Diabetologia
- Vol. 39 (10) , 1223-1226
Abstract
Insulin, glutamate decarboxylase (GAD) and the protein tyrosine phosphatase-like molecule IA-2 are major targets of humoral autoimmunity in insulin-dependent diabetes mellitus (IDDM). These autoantibodies are heterogeneous with respect to age and patient human leukocyte antigen (HLA) phenotype. We have previously demonstrated that GAD and IA-2 antibodies potentially identify different subsets of IDDM patients. The aim of this study was to determine whether GAD and IA-2 autoantibodies were associated with different HLA DR phenotypes. We studied 160 patients with IDDM onset before age 16 years. At disease onset serum was tested for GAD and IA-2 antibodies by immunoprecipitation of in vitro-translated35S-methionine labelled recombinant proteins. IA-2 antibodies were significantly associated with HLA DR4: 67 (86 %) of 78 patients with HLA DR4 vs 31 (38 %) of 82 non-DR4 patients had IA-2 antibodies (p cp cp cp c<0.01) in patients with HLA DR3 phenotypes. These data provide further evidence that, in IDDM, production and titre of major autoantibody specificities are associated with HLA class II alleles.Keywords
This publication has 17 references indexed in Scilit:
- Relationship of the 37,000- and 40,000-M(r) tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512).Journal of Clinical Investigation, 1995
- Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivityDiabetologia, 1995
- Glutamate decarboxylase-, insulin-, and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children.Journal of Clinical Investigation, 1995
- Combined Analysis of Autoantibodies Improves Prediction of IDDM in Islet Cell Antibody-Positive RelativesDiabetes, 1994
- Antibodies to Islet 37k Antigen, But Not to Glutamate Decarboxylase, Discriminate Rapid Progression to IDDM in Endocrine AutoimmunityDiabetes, 1994
- HLA-DQ genotypes are associated with autoimmunity to glutamic acid decarboxylase in insulin-dependent diabetes mellitus patientsHuman Immunology, 1993
- Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylaseNature, 1990
- HLA-DR 3 is associated with a more slowly progressive form of Type 1 (insulin-dependent) diabetesDiabetologia, 1986
- HLA Heterogeneity of Insulin-dependent Diabetes Mellitus at Diagnosis: The Pittsburgh IDDM StudyDiabetes, 1985
- Insulin Antibodies in Insulin-Dependent Diabetics Before Insulin TreatmentScience, 1983